Urges NJ DOH to increase public awareness on effects of xylazine.
SR 38 is a Senate Resolution urging the New Jersey Department of Health to increase public awareness about the dangers of xylazine, a non-opioid veterinary tranquilizer misused as a street drug. It directly affects New Jersey residents by calling for educational resources on xylazine's risks, including its link to overdose deaths (as it cannot be reversed by naloxone), skin ulcers, and dangerous combinations with fentanyl or other drugs. The resolution does not create new laws but requests the health department develop public outreach materials. It highlights xylazine's role in the Northeast overdose crisis, noting its use via injection, snorting, or mixing with opioids.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026
Last action Jan 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SR 38
Scope: NJ
Hi! I can help you understand SR 38. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline